Clin Mol Hepatol.
2023 Jan;29(1):168. 10.3350/cmh.2022.0328.
Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
- Affiliations
-
- 1Private Academic Consultant, Bangkok, Thailand
- 2Department of Research Center, Chandigarh University, Punjab, India
- KMID: 2538214
- DOI: http://doi.org/10.3350/cmh.2022.0328
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
- COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
- Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients: a single center study
- Different antibody responses between liver and kidney transplant recipients elicited by third doses of COVID-19 mRNA vaccines
- Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic
